Retraction Watch

Exclusive: Wiley journal editor under investigation for duplicate publications

An academic editor at Wiley who vowed to “uphold publication ethics” is being investigated by the company for allegedly publishing three of his papers twice, in violation of journal policies, Retraction Watch has learned.

One of the duplicates, which appeared last year in Nurse Education in Practice, an Elsevier title, has already been slated for retraction, according to emails we have seen. The other offending articles were published in Wiley journals.

The editor, Daniel Joseph Berdida, is a nurse and faculty member at the University of Santo Tomas in Manila, the Philippines. He joined the editorial board of Wiley’s Journal of Nursing Management four months ago, announcing on LinkedIn that he would “be serving with integrity and uphold publication ethics.”

The dean who came to visit – and added dozens of authors without their knowledge

Earlier this year, a group of lecturers in Malaysia received a WhatsApp message from a colleague who had made a disturbing discovery.

The colleague, who wished to remain anonymous for this story, was looking through Google Scholar and noticed their name, and many others from their department, repeatedly appeared alongside that of an unfamiliar author: Kumba Digdowiseiso, dean of the economics and business faculty at Universitas Nasional in Jakarta, Indonesia.

“We didn’t even know who this person was,” said Safwan Mohd Nor, an associate professor of finance at the university, Universiti Malaysia Terengganu, adding that he was “extremely angry” when he first found out his name had been used.

Publisher flags papers found by university to involve misconduct more than a year ago

Toxicologic Pathology – a Sage title – has issued expressions of concern for six papers that were among the subjects of an investigation by Azabu University that concluded in November 2022.

The expression of concern, dated March 7, 2024, includes a list of the six articles and reads:

Weekend reads: ‘Objectionable conditions’ at psychiatry institute; impact factor obsession; Nobel winner acknowledges more errors

Would you consider a donation to support Weekend Reads, and our daily work?

The week at Retraction Watch featured:

Our list of retracted or withdrawn COVID-19 papers is up past 400. There are more than 48,000 retractions in The Retraction Watch Database — which is now part of Crossref. The Retraction Watch Hijacked Journal Checker now contains more than 250 titles. And have you seen our leaderboard of authors with the most retractions lately — or our list of top 10 most highly cited retracted papers? What about The Retraction Watch Mass Resignations List — or our list of papers with evidence they were written by ChatGPT?

Here’s what was happening elsewhere (some of these items may be paywalled, metered access, or require free registration to read):

Cureus reviewing paper alleged to plagiarize Lancet article

A 2022 paper in Cureus on causes of cancer around the world is under investigation by the journal following inquiries by Retraction Watch prompted by a reader’s email.

The paper, “Causes of Cancer in the World: Comparative Risk Assessment of Nine Behavioral and Environmental Risk Factors,” shares a title and figures with a 2005 paper in The Lancet. It also “follows the Lancet one on a sentence-by-sentence level while using tortured phrases,” an anonymous tipster told us.

As we’ve noted elsewhere in a report on the team that developed the phrase, “Tortured phrases are what happens to words that get translated from English into a foreign language, then back to English — perhaps by a computer trying to generate a scholarly publication for a group of unscrupulous authors.”

Embattled researcher Didier Raoult earns more than 100 expressions of concern and another retraction

An Elsevier journal has issued just over 100 expressions of concern for papers published by a group of researchers led by the French microbiologist Didier Raoult, who also notched a new retraction – his tenth – in a separate publication.

As we and others have reported, Raoult’s work during the COVID-19 pandemic drew intense scrutiny from data sleuths, most notably Elisabeth Bik – whose critiques, which extended beyond his COVID studies, were met with vicious online trolling and a legal complaint filed by Raoult himself.

The allegations prompted an ethics investigation by the French National Agency for the Safety of Medicines and Health Products into Raoult’s research during his tenure at the IHU Méditerranée Infection, in Marseille, which he led between 2011 and his retirement as director in 2022. That inquiry found “serious shortcomings and non-compliances with the regulations for research involving the human person.”

The 101 expressions of concern come for papers Raoult and his colleagues published in New Microbes and New Infections. Here’s an example of one of the EoC’s, for “Genome sequence and description of Anaerosalibacter massiliensis sp. nov.,” which Raoult’s group published in March 2016:

High-profile ob-gyn accused of duplicating data threatens to sue critic

Sometime last summer, Ben Mol, an obstetrician-gynecology researcher in Australia, and his colleagues were adapting a European guideline on unexplained infertility when they came across a 2006 paper from Maria Luisa Casini, a pharmacologist in Rome, that gave them pause because of results that were not statistically significant.

When they looked further, they ended in a rabbit hole. Casini’s previous work revealed identical patient data across papers published two years apart, despite purporting to come from different groups of patients. The similarities were striking: In the 2006 paper, the women’s mean height was 165.5 centimeters; in the study published two years earlier that reported having more than triple the number of participants, the women had the exact same mean height, with the same standard deviation.

The guideline update would eventually lead to half of the included trials being flagged for integrity issues, and as a result, left out of the Australian version of the guideline. From that one paper by Casini that had initially raised doubts, the team was able to unearth a trail of suspicious data connected to several ob-gyns in Italy. An Italian medical society and one of the implicated authors have threatened to sue over the allegations, claiming the complaints were made to interfere with a high-profile society election, but the papers are now part of a wider Elsevier investigation.

Paper claiming vaping tops nicotine gum for smoking cessation retracted from JAMA journal

A JAMA journal has retracted a paper on vaping it published two months ago after the researchers alerted the editors to “significant coding errors” and other problems with the work.

The article, “Efficacy of Electronic Cigarettes vs Varenicline and Nicotine Chewing Gum as an Aid to Stop Smoking: A Randomized Clinical Trial,” was written by a group from China led by Zhao Liu, of the Department of Tobacco Control and Prevention of Respiratory Disease at China-Japan Friendship Hospital, in Beijing.

According to the researchers, the study found use of vapes was no worse than a prescription medication, and better than nicotine gum, at helping people quit smoking.

The paper received a significant amount of attention in the medical and lay press and on social media (full disclosure: Medscape, where Adam works, covered it).

Here’s the March 29 retraction notice for the paper, which originally appeared online in JAMA Internal Medicine January 29:

Exclusive: ‘Bust Size and Hitchhiking’ author to earn four more expressions of concern

The journal Social Influence will be issuing expressions of concern for four papers by Nicolas Guéguen, a marketing researcher whose work has long been dogged by allegations, Retraction Watch has learned.

Guéguen has to date has lost at least three papers to retraction, and has received many more expressions of concern, for his questionable studies. However, his institution, the Université de Bretagne-Sud, cleared him of wrongdoing in 2019.

Guéguen made a name for himself for his quirky studies – often about human sexuality – like one purporting to find women with bigger breasts were more likely to be successful hitchhikers; and one which claimed to find men with guitar cases are more attractive to women. (The first of those articles has an expression of concern; the second was retracted in 2020.)

Chief researcher at national Japanese institute has paper retracted for faking data

An official journal of the Japanese government has retracted a 2021 paper over concerns about misconduct in the work, which was performed in a national research center.

Here’s the retraction notice for the paper, titled “Development and Evaluation of Fluorescence Immunochomatography for Rapid and Sensitive Detection of Thermophilic Campylobacter”:

Food Safety decided to retract this article in which the primary author misconducted as reported from the primary author’s affiliation.

Far more details are available in materials published last December by Japan’s National Institute of Health Sciences, where the first author of the article, Hiroshi Asakura, is chief researcher. According to a press release dated Dec. 26, 2023:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: